skin depigmentation

Dr. Seemal Desai presented information about vitiligo and provided updates about emerging treatment options. Vitiligo is a chronic autoimmune disease that targets melanocytes, causing skin depigmentation. Its pathogenesis is largely regulated by interferon-γ activation of the Janus kinase (JAK) signaling pathway. First, Desai described treatment options for vitiligo, including topical and systemic therapies, phototherapy, depigmentation…